MEDIPOST’s Clinical Trial of Next-Generation Cell Therapy Product ‘SMUP-IA-01’ Makes Solid Progress

MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in Japan

MEDIPOST completes the phase 1 clinical trial of its injectable drug for knee osteoarthritis, SMUP-IA-01

MEDIPOST receives approval for processing the phase 3 clinical trial of CARTISTEM in Japan

MEDIPOST’s phase 1 clinical trial results for its injectable drug for knee osteoarthritis in Korea show improvements in safety and clinical symptoms

MEDIPOST’s treatment for knee osteoarthritis, enters phase 3 clinical trials in Japan